Hikma Pharmaceuticals PLC develops, manufactures, and markets pharmaceutical products. The Company offers branded and non-branded generic and in-licensed pharmaceutical products. Hikma Pharmaceuticals serves customers worldwide.
Market Cap: £4.79Billion
The long-term trend on Hikma remains . The corrective move lower in recent weeks has found some support at the 38.2% Fibonacci level. The posting of a candle while simultaneously breaking from a pattern is for short term sentiment. Further upside is expected from here, targeting the previous highs at 2345p from 15th March 2017.
Target 1: 2210p
Target 2: 2345p
Target 3: 2400p
Interested in UK Stocks?
Join our free Telegram channel for up to date analysis on the best main market opportunities in the UK right now - https://t.me/UK_Stocks